Vanda Pharmaceuticals Inc (VNDA) Business News Nov. 28, 2025, 12:00 UTC Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness Full text
Register to leave comments News bot Nov. 28, 2025, 12:15 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business